Cargando…

Trends in Inpatient Chemotherapy Hospitalizations, Cost and Mortality for Patients with Acute Leukemias and Myeloma

Detalles Bibliográficos
Autores principales: Gil, Kellen, Abbasi, Saqib, Mehta, Kathan, McClune, Brian, Sborov, Douglas, Ahmed, Nausheen, Abdallah, Al-Ola, Ganguly, Siddhartha, McGuirk, Joseph, Shune, Leyla, Mohyuddin, Ghulam Rehman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358787/
https://www.ncbi.nlm.nih.gov/pubmed/35950203
http://dx.doi.org/10.1007/s44228-022-00003-9
_version_ 1784764004450697216
author Gil, Kellen
Abbasi, Saqib
Mehta, Kathan
McClune, Brian
Sborov, Douglas
Ahmed, Nausheen
Abdallah, Al-Ola
Ganguly, Siddhartha
McGuirk, Joseph
Shune, Leyla
Mohyuddin, Ghulam Rehman
author_facet Gil, Kellen
Abbasi, Saqib
Mehta, Kathan
McClune, Brian
Sborov, Douglas
Ahmed, Nausheen
Abdallah, Al-Ola
Ganguly, Siddhartha
McGuirk, Joseph
Shune, Leyla
Mohyuddin, Ghulam Rehman
author_sort Gil, Kellen
collection PubMed
description
format Online
Article
Text
id pubmed-9358787
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-93587872022-08-09 Trends in Inpatient Chemotherapy Hospitalizations, Cost and Mortality for Patients with Acute Leukemias and Myeloma Gil, Kellen Abbasi, Saqib Mehta, Kathan McClune, Brian Sborov, Douglas Ahmed, Nausheen Abdallah, Al-Ola Ganguly, Siddhartha McGuirk, Joseph Shune, Leyla Mohyuddin, Ghulam Rehman Clin Hematol Int Correspondence Springer Netherlands 2022-05-11 /pmc/articles/PMC9358787/ /pubmed/35950203 http://dx.doi.org/10.1007/s44228-022-00003-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correspondence
Gil, Kellen
Abbasi, Saqib
Mehta, Kathan
McClune, Brian
Sborov, Douglas
Ahmed, Nausheen
Abdallah, Al-Ola
Ganguly, Siddhartha
McGuirk, Joseph
Shune, Leyla
Mohyuddin, Ghulam Rehman
Trends in Inpatient Chemotherapy Hospitalizations, Cost and Mortality for Patients with Acute Leukemias and Myeloma
title Trends in Inpatient Chemotherapy Hospitalizations, Cost and Mortality for Patients with Acute Leukemias and Myeloma
title_full Trends in Inpatient Chemotherapy Hospitalizations, Cost and Mortality for Patients with Acute Leukemias and Myeloma
title_fullStr Trends in Inpatient Chemotherapy Hospitalizations, Cost and Mortality for Patients with Acute Leukemias and Myeloma
title_full_unstemmed Trends in Inpatient Chemotherapy Hospitalizations, Cost and Mortality for Patients with Acute Leukemias and Myeloma
title_short Trends in Inpatient Chemotherapy Hospitalizations, Cost and Mortality for Patients with Acute Leukemias and Myeloma
title_sort trends in inpatient chemotherapy hospitalizations, cost and mortality for patients with acute leukemias and myeloma
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358787/
https://www.ncbi.nlm.nih.gov/pubmed/35950203
http://dx.doi.org/10.1007/s44228-022-00003-9
work_keys_str_mv AT gilkellen trendsininpatientchemotherapyhospitalizationscostandmortalityforpatientswithacuteleukemiasandmyeloma
AT abbasisaqib trendsininpatientchemotherapyhospitalizationscostandmortalityforpatientswithacuteleukemiasandmyeloma
AT mehtakathan trendsininpatientchemotherapyhospitalizationscostandmortalityforpatientswithacuteleukemiasandmyeloma
AT mcclunebrian trendsininpatientchemotherapyhospitalizationscostandmortalityforpatientswithacuteleukemiasandmyeloma
AT sborovdouglas trendsininpatientchemotherapyhospitalizationscostandmortalityforpatientswithacuteleukemiasandmyeloma
AT ahmednausheen trendsininpatientchemotherapyhospitalizationscostandmortalityforpatientswithacuteleukemiasandmyeloma
AT abdallahalola trendsininpatientchemotherapyhospitalizationscostandmortalityforpatientswithacuteleukemiasandmyeloma
AT gangulysiddhartha trendsininpatientchemotherapyhospitalizationscostandmortalityforpatientswithacuteleukemiasandmyeloma
AT mcguirkjoseph trendsininpatientchemotherapyhospitalizationscostandmortalityforpatientswithacuteleukemiasandmyeloma
AT shuneleyla trendsininpatientchemotherapyhospitalizationscostandmortalityforpatientswithacuteleukemiasandmyeloma
AT mohyuddinghulamrehman trendsininpatientchemotherapyhospitalizationscostandmortalityforpatientswithacuteleukemiasandmyeloma